Identification	O
of	O
Left	B:C0023212
Ventricle	I:C0023212
Failure	I:C0023212
on	O
Pulmonary	O
Artery	O
CTA	O
:	O
Diagnostic	O
Significance	O
of	O
Decreased	O
Aortic	I:C0003504
&	O
Left	O
Ventricle	I:C0149721
Enhancement	I:C0149721
.	O

Identification	O
of	O
Left	O
Ventricle	I:C0023212
Failure	I:C0023212
on	O
Pulmonary	O
Artery	O
CTA	B:C1536105
:	O
Diagnostic	O
Significance	O
of	O
Decreased	O
Aortic	I:C0003504
&	O
Left	O
Ventricle	I:C0149721
Enhancement	I:C0149721
.	O

Identification	O
of	O
Left	O
Ventricle	I:C0023212
Failure	I:C0023212
on	O
Pulmonary	O
Artery	O
CTA	O
:	O
Diagnostic	O
Significance	O
of	O
Decreased	B:C0003504
Aortic	I:C0003504
&	O
Left	O
Ventricle	I:C0149721
Enhancement	I:C0149721
.	O

Identification	O
of	O
Left	O
Ventricle	I:C0023212
Failure	I:C0023212
on	O
Pulmonary	O
Artery	O
CTA	O
:	O
Diagnostic	O
Significance	O
of	O
Decreased	O
Aortic	I:C0003504
&	O
Left	B:C0149721
Ventricle	I:C0149721
Enhancement	I:C0149721
.	O

This	O
study	B:C0008972
aimed	O
to	O
identify	O
findings	O
on	O
non-	O
ECG	O
-	O
gated	O
CT	O
pulmonary	I:C1641850
angiography	I:C1641850
(	O
CT	O
pulmonary	I:C1641850
angiography	I:C1641850
)	O
indicating	O
decreased	O
left	O
ventricle	I:C0225897
(	O
left	O
ventricle	I:C0225897
)	O
systolic	O
function	I:C4025008
,	O
later	O
confirmed	O
by	O
echocardiogram	O
.	O

This	O
study	O
aimed	O
to	O
identify	O
findings	O
on	O
non-	O
ECG	B:C0013798
-	O
gated	O
CT	O
pulmonary	I:C1641850
angiography	I:C1641850
(	O
CT	O
pulmonary	I:C1641850
angiography	I:C1641850
)	O
indicating	O
decreased	O
left	O
ventricle	I:C0225897
(	O
left	O
ventricle	I:C0225897
)	O
systolic	O
function	I:C4025008
,	O
later	O
confirmed	O
by	O
echocardiogram	O
.	O

This	O
study	O
aimed	O
to	O
identify	O
findings	O
on	O
non-	O
ECG	O
-	O
gated	O
CT	B:C1641850
pulmonary	I:C1641850
angiography	I:C1641850
(	O
CT	O
pulmonary	I:C1641850
angiography	I:C1641850
)	O
indicating	O
decreased	O
left	O
ventricle	I:C0225897
(	O
left	O
ventricle	I:C0225897
)	O
systolic	O
function	I:C4025008
,	O
later	O
confirmed	O
by	O
echocardiogram	O
.	O

This	O
study	O
aimed	O
to	O
identify	O
findings	O
on	O
non-	O
ECG	O
-	O
gated	O
CT	O
pulmonary	I:C1641850
angiography	I:C1641850
(	O
CT	B:C1641850
pulmonary	I:C1641850
angiography	I:C1641850
)	O
indicating	O
decreased	O
left	O
ventricle	I:C0225897
(	O
left	O
ventricle	I:C0225897
)	O
systolic	O
function	I:C4025008
,	O
later	O
confirmed	O
by	O
echocardiogram	O
.	O

This	O
study	O
aimed	O
to	O
identify	O
findings	O
on	O
non-	O
ECG	O
-	O
gated	O
CT	O
pulmonary	I:C1641850
angiography	I:C1641850
(	O
CT	O
pulmonary	I:C1641850
angiography	I:C1641850
)	O
indicating	O
decreased	O
left	B:C0225897
ventricle	I:C0225897
(	O
left	O
ventricle	I:C0225897
)	O
systolic	O
function	I:C4025008
,	O
later	O
confirmed	O
by	O
echocardiogram	O
.	O

This	O
study	O
aimed	O
to	O
identify	O
findings	O
on	O
non-	O
ECG	O
-	O
gated	O
CT	O
pulmonary	I:C1641850
angiography	I:C1641850
(	O
CT	O
pulmonary	I:C1641850
angiography	I:C1641850
)	O
indicating	O
decreased	O
left	O
ventricle	I:C0225897
(	O
left	B:C0225897
ventricle	I:C0225897
)	O
systolic	O
function	I:C4025008
,	O
later	O
confirmed	O
by	O
echocardiogram	O
.	O

This	O
study	O
aimed	O
to	O
identify	O
findings	O
on	O
non-	O
ECG	O
-	O
gated	O
CT	O
pulmonary	I:C1641850
angiography	I:C1641850
(	O
CT	O
pulmonary	I:C1641850
angiography	I:C1641850
)	O
indicating	O
decreased	O
left	O
ventricle	I:C0225897
(	O
left	O
ventricle	I:C0225897
)	O
systolic	B:C4025008
function	I:C4025008
,	O
later	O
confirmed	O
by	O
echocardiogram	O
.	O

This	O
study	O
aimed	O
to	O
identify	O
findings	O
on	O
non-	O
ECG	O
-	O
gated	O
CT	O
pulmonary	I:C1641850
angiography	I:C1641850
(	O
CT	O
pulmonary	I:C1641850
angiography	I:C1641850
)	O
indicating	O
decreased	O
left	O
ventricle	I:C0225897
(	O
left	O
ventricle	I:C0225897
)	O
systolic	O
function	I:C4025008
,	O
later	O
confirmed	O
by	O
echocardiogram	B:C2243117
.	O

After	O
obtaining	O
institutional	B:C2346499
review	I:C2346499
board	I:C2346499
approval	I:C2346499
,	O
review	O
was	O
performed	O
of	O
emergency	O
department	I:C0374899
(	O
emergency	O
department	I:C0374899
)	O
patients	O
who	O
had	O
CT	O
pulmonary	I:C1641850
angiography	I:C1641850
and	O
follow	O
-	O
up	O
echocardiogram	O
within	O
48	O
h	O
,	O
over	O
18	O
months	O
.	O

After	O
obtaining	O
institutional	O
review	I:C2346499
board	I:C2346499
approval	I:C2346499
,	O
review	O
was	O
performed	O
of	O
emergency	B:C0374899
department	I:C0374899
(	O
emergency	O
department	I:C0374899
)	O
patients	O
who	O
had	O
CT	O
pulmonary	I:C1641850
angiography	I:C1641850
and	O
follow	O
-	O
up	O
echocardiogram	O
within	O
48	O
h	O
,	O
over	O
18	O
months	O
.	O

After	O
obtaining	O
institutional	O
review	I:C2346499
board	I:C2346499
approval	I:C2346499
,	O
review	O
was	O
performed	O
of	O
emergency	O
department	I:C0374899
(	O
emergency	B:C0374899
department	I:C0374899
)	O
patients	O
who	O
had	O
CT	O
pulmonary	I:C1641850
angiography	I:C1641850
and	O
follow	O
-	O
up	O
echocardiogram	O
within	O
48	O
h	O
,	O
over	O
18	O
months	O
.	O

After	O
obtaining	O
institutional	O
review	I:C2346499
board	I:C2346499
approval	I:C2346499
,	O
review	O
was	O
performed	O
of	O
emergency	O
department	I:C0374899
(	O
emergency	O
department	I:C0374899
)	O
patients	O
who	O
had	O
CT	B:C1641850
pulmonary	I:C1641850
angiography	I:C1641850
and	O
follow	O
-	O
up	O
echocardiogram	O
within	O
48	O
h	O
,	O
over	O
18	O
months	O
.	O

After	O
obtaining	O
institutional	O
review	I:C2346499
board	I:C2346499
approval	I:C2346499
,	O
review	O
was	O
performed	O
of	O
emergency	O
department	I:C0374899
(	O
emergency	O
department	I:C0374899
)	O
patients	O
who	O
had	O
CT	O
pulmonary	I:C1641850
angiography	I:C1641850
and	O
follow	O
-	O
up	O
echocardiogram	B:C2243117
within	O
48	O
h	O
,	O
over	O
18	O
months	O
.	O

Patients	O
with	O
pulmonary	B:C0034065
embolus	I:C0034065
,	O
suboptimal	O
CT	O
pulmonary	I:C1641850
angiography	I:C1641850
,	O
arrhythmias	O
or	O
pericardial	O
tamponade	I:C0007177
were	O
excluded	O
.	O

Patients	O
with	O
pulmonary	O
embolus	I:C0034065
,	O
suboptimal	O
CT	B:C1641850
pulmonary	I:C1641850
angiography	I:C1641850
,	O
arrhythmias	O
or	O
pericardial	O
tamponade	I:C0007177
were	O
excluded	O
.	O

Patients	O
with	O
pulmonary	O
embolus	I:C0034065
,	O
suboptimal	O
CT	O
pulmonary	I:C1641850
angiography	I:C1641850
,	O
arrhythmias	B:C0003811
or	O
pericardial	O
tamponade	I:C0007177
were	O
excluded	O
.	O

Patients	O
with	O
pulmonary	O
embolus	I:C0034065
,	O
suboptimal	O
CT	O
pulmonary	I:C1641850
angiography	I:C1641850
,	O
arrhythmias	O
or	O
pericardial	B:C0007177
tamponade	I:C0007177
were	O
excluded	O
.	O

One	O
hundred	O
thirty	O
-	O
seven	O
patients	O
were	O
identified	O
and	O
divided	O
into	O
cases	O
(	O
LVEF	B:C0428772
<	O
40	O
%	O
,	O
n	O
=	O
52	O
)	O
and	O
controls	O
(	O
LVEF	O
>50	O
%	O
,	O
n	O
=	O
85	O
)	O
.	O

One	O
hundred	O
thirty	O
-	O
seven	O
patients	O
were	O
identified	O
and	O
divided	O
into	O
cases	O
(	O
LVEF	O
<	O
40	O
%	O
,	O
n	O
=	O
52	O
)	O
and	O
controls	O
(	O
LVEF	B:C0428772
>50	O
%	O
,	O
n	O
=	O
85	O
)	O
.	O

Two	O
reviewers	B:C1882950
performed	O
these	O
analyses	O
:	O
measurement	O
of	O
enhancement	O
in	O
main	O
pulmonary	O
artery	O
(	O
MPA	O
)	O
,	O
left	O
ventricle	I:C0225897
,	O
and	O
aorta	O
;	O
subjective	O
enhancement	O
of	I:C0149721
LV	I:C0149721
and	O
aorta	O
(	O
aorta	O
)	O
relative	O
to	O
MPA	O
using	O
a	O
four	O
-	O
point	O
Likert	O
scale	I:C0451267
;	O
contrast	O
transit	O
time	O
(	O
TD	O
)	O
to	O
trigger	O
CT	O
pulmonary	I:C1641850
angiography	I:C1641850
and	O
left	O
ventricle	I:C0225897
short	O
&	O
long	O
axis	O
dimensions	O
.	O

Two	O
reviewers	O
performed	O
these	O
analyses	B:C0936012
:	O
measurement	O
of	O
enhancement	O
in	O
main	O
pulmonary	O
artery	O
(	O
MPA	O
)	O
,	O
left	O
ventricle	I:C0225897
,	O
and	O
aorta	O
;	O
subjective	O
enhancement	O
of	I:C0149721
LV	I:C0149721
and	O
aorta	O
(	O
aorta	O
)	O
relative	O
to	O
MPA	O
using	O
a	O
four	O
-	O
point	O
Likert	O
scale	I:C0451267
;	O
contrast	O
transit	O
time	O
(	O
TD	O
)	O
to	O
trigger	O
CT	O
pulmonary	I:C1641850
angiography	I:C1641850
and	O
left	O
ventricle	I:C0225897
short	O
&	O
long	O
axis	O
dimensions	O
.	O

Two	O
reviewers	O
performed	O
these	O
analyses	O
:	O
measurement	O
of	O
enhancement	O
in	O
main	O
pulmonary	O
artery	O
(	O
MPA	O
)	O
,	O
left	B:C0225897
ventricle	I:C0225897
,	O
and	O
aorta	O
;	O
subjective	O
enhancement	O
of	I:C0149721
LV	I:C0149721
and	O
aorta	O
(	O
aorta	O
)	O
relative	O
to	O
MPA	O
using	O
a	O
four	O
-	O
point	O
Likert	O
scale	I:C0451267
;	O
contrast	O
transit	O
time	O
(	O
TD	O
)	O
to	O
trigger	O
CT	O
pulmonary	I:C1641850
angiography	I:C1641850
and	O
left	O
ventricle	I:C0225897
short	O
&	O
long	O
axis	O
dimensions	O
.	O

Two	O
reviewers	O
performed	O
these	O
analyses	O
:	O
measurement	O
of	O
enhancement	O
in	O
main	O
pulmonary	O
artery	O
(	O
MPA	O
)	O
,	O
left	O
ventricle	I:C0225897
,	O
and	O
aorta	B:C0003483
;	O
subjective	O
enhancement	O
of	I:C0149721
LV	I:C0149721
and	O
aorta	O
(	O
aorta	O
)	O
relative	O
to	O
MPA	O
using	O
a	O
four	O
-	O
point	O
Likert	O
scale	I:C0451267
;	O
contrast	O
transit	O
time	O
(	O
TD	O
)	O
to	O
trigger	O
CT	O
pulmonary	I:C1641850
angiography	I:C1641850
and	O
left	O
ventricle	I:C0225897
short	O
&	O
long	O
axis	O
dimensions	O
.	O

Two	O
reviewers	O
performed	O
these	O
analyses	O
:	O
measurement	O
of	O
enhancement	O
in	O
main	O
pulmonary	O
artery	O
(	O
MPA	O
)	O
,	O
left	O
ventricle	I:C0225897
,	O
and	O
aorta	O
;	O
subjective	O
enhancement	B:C0149721
of	I:C0149721
LV	I:C0149721
and	O
aorta	O
(	O
aorta	O
)	O
relative	O
to	O
MPA	O
using	O
a	O
four	O
-	O
point	O
Likert	O
scale	I:C0451267
;	O
contrast	O
transit	O
time	O
(	O
TD	O
)	O
to	O
trigger	O
CT	O
pulmonary	I:C1641850
angiography	I:C1641850
and	O
left	O
ventricle	I:C0225897
short	O
&	O
long	O
axis	O
dimensions	O
.	O

Two	O
reviewers	O
performed	O
these	O
analyses	O
:	O
measurement	O
of	O
enhancement	O
in	O
main	O
pulmonary	O
artery	O
(	O
MPA	O
)	O
,	O
left	O
ventricle	I:C0225897
,	O
and	O
aorta	O
;	O
subjective	O
enhancement	O
of	I:C0149721
LV	I:C0149721
and	O
aorta	B:C0003486
(	O
aorta	O
)	O
relative	O
to	O
MPA	O
using	O
a	O
four	O
-	O
point	O
Likert	O
scale	I:C0451267
;	O
contrast	O
transit	O
time	O
(	O
TD	O
)	O
to	O
trigger	O
CT	O
pulmonary	I:C1641850
angiography	I:C1641850
and	O
left	O
ventricle	I:C0225897
short	O
&	O
long	O
axis	O
dimensions	O
.	O

Two	O
reviewers	O
performed	O
these	O
analyses	O
:	O
measurement	O
of	O
enhancement	O
in	O
main	O
pulmonary	O
artery	O
(	O
MPA	O
)	O
,	O
left	O
ventricle	I:C0225897
,	O
and	O
aorta	O
;	O
subjective	O
enhancement	O
of	I:C0149721
LV	I:C0149721
and	O
aorta	O
(	O
aorta	B:C0003486
)	O
relative	O
to	O
MPA	O
using	O
a	O
four	O
-	O
point	O
Likert	O
scale	I:C0451267
;	O
contrast	O
transit	O
time	O
(	O
TD	O
)	O
to	O
trigger	O
CT	O
pulmonary	I:C1641850
angiography	I:C1641850
and	O
left	O
ventricle	I:C0225897
short	O
&	O
long	O
axis	O
dimensions	O
.	O

Two	O
reviewers	O
performed	O
these	O
analyses	O
:	O
measurement	O
of	O
enhancement	O
in	O
main	O
pulmonary	O
artery	O
(	O
MPA	O
)	O
,	O
left	O
ventricle	I:C0225897
,	O
and	O
aorta	O
;	O
subjective	O
enhancement	O
of	I:C0149721
LV	I:C0149721
and	O
aorta	O
(	O
aorta	O
)	O
relative	O
to	O
MPA	O
using	O
a	O
four	O
-	O
point	O
Likert	B:C0451267
scale	I:C0451267
;	O
contrast	O
transit	O
time	O
(	O
TD	O
)	O
to	O
trigger	O
CT	O
pulmonary	I:C1641850
angiography	I:C1641850
and	O
left	O
ventricle	I:C0225897
short	O
&	O
long	O
axis	O
dimensions	O
.	O

Two	O
reviewers	O
performed	O
these	O
analyses	O
:	O
measurement	O
of	O
enhancement	O
in	O
main	O
pulmonary	O
artery	O
(	O
MPA	O
)	O
,	O
left	O
ventricle	I:C0225897
,	O
and	O
aorta	O
;	O
subjective	O
enhancement	O
of	I:C0149721
LV	I:C0149721
and	O
aorta	O
(	O
aorta	O
)	O
relative	O
to	O
MPA	O
using	O
a	O
four	O
-	O
point	O
Likert	O
scale	I:C0451267
;	O
contrast	O
transit	O
time	O
(	O
TD	O
)	O
to	O
trigger	O
CT	B:C1641850
pulmonary	I:C1641850
angiography	I:C1641850
and	O
left	O
ventricle	I:C0225897
short	O
&	O
long	O
axis	O
dimensions	O
.	O

Two	O
reviewers	O
performed	O
these	O
analyses	O
:	O
measurement	O
of	O
enhancement	O
in	O
main	O
pulmonary	O
artery	O
(	O
MPA	O
)	O
,	O
left	O
ventricle	I:C0225897
,	O
and	O
aorta	O
;	O
subjective	O
enhancement	O
of	I:C0149721
LV	I:C0149721
and	O
aorta	O
(	O
aorta	O
)	O
relative	O
to	O
MPA	O
using	O
a	O
four	O
-	O
point	O
Likert	O
scale	I:C0451267
;	O
contrast	O
transit	O
time	O
(	O
TD	O
)	O
to	O
trigger	O
CT	O
pulmonary	I:C1641850
angiography	I:C1641850
and	O
left	B:C0225897
ventricle	I:C0225897
short	O
&	O
long	O
axis	O
dimensions	O
.	O

When	O
available	O
,	O
the	O
most	O
recent	O
N	B:C0754710
-	I:C0754710
terminal	I:C0754710
pro-B	I:C0754710
-type	I:C0754710
natriuretic	I:C0754710
peptide	I:C0754710
(	O
N	O
-	I:C0754710
terminal	I:C0754710
pro-B-	I:C0754710
type	I:C0754710
natriuretic	I:C0754710
peptide	I:C0754710
)	O
level	O
was	O
recorded	O
.	O

When	O
available	O
,	O
the	O
most	O
recent	O
N	O
-	I:C0754710
terminal	I:C0754710
pro-B	I:C0754710
-type	I:C0754710
natriuretic	I:C0754710
peptide	I:C0754710
(	O
N	B:C0754710
-	I:C0754710
terminal	I:C0754710
pro-B-	I:C0754710
type	I:C0754710
natriuretic	I:C0754710
peptide	I:C0754710
)	O
level	O
was	O
recorded	O
.	O

Decreased	B:C0003504
aortic	I:C0003504
and	O
LV	O
subjective	I:C0149721
enhancement	I:C0149721
were	O
the	O
best	O
predictors	O
of	O
LV	O
systolic	I:C1277187
dysfunction	I:C1277187
.	O

Decreased	O
aortic	I:C0003504
and	O
LV	B:C0149721
subjective	I:C0149721
enhancement	I:C0149721
were	O
the	O
best	O
predictors	O
of	O
LV	O
systolic	I:C1277187
dysfunction	I:C1277187
.	O

Decreased	O
aortic	I:C0003504
and	O
LV	O
subjective	I:C0149721
enhancement	I:C0149721
were	O
the	O
best	O
predictors	O
of	O
LV	B:C1277187
systolic	I:C1277187
dysfunction	I:C1277187
.	O

For	O
aorta	B:C0003486
/	O
MPA	O
ratio	O
,	O
an	O
optimal	O
cutoff	O
value	O
of	O
0.20	O
resulted	O
in	O
a	O
sensitivity	O
of	O
0.54	O
and	O
specificity	O
of	O
0.93	O
(	O
AUC	O
=	O
0.83	O
,	O
0.78-0.88	O
95	O
%	O
CI	O
)	O
.	O

A	O
threshold	O
of	O
86.7	O
HU	O
for	O
aorta	B:C0003486
enhancement	O
resulted	O
in	O
a	O
sensitivity	O
of	O
0.68	O
and	O
specificity	O
of	O
0.90	O
(	O
AUC	O
=	O
0.82	O
,	O
0.77-0.88	O
95	O
%	O
CI	O
)	O
.	O

A	O
LV	B:C0455834
short	I:C0455834
axis	I:C0455834
diameter	I:C0455834
of	O
more	O
than	O
54.3	O
mm	O
had	O
a	O
sensitivity	O
of	O
0.62	O
and	O
specificity	O
of	O
0.98	O
(	O
AUC	O
=	O
0.88	O
,	O
0.83-0.92	O
95	O
%	O
CI	O
)	O
.	O

Unsuspected	O
LV	B:C1277187
systolic	I:C1277187
dysfunction	I:C1277187
can	O
be	O
recognized	O
on	O
a	O
CT	O
pulmonary	I:C1641850
angiography	I:C1641850
by	O
identification	O
of	O
decreased	O
aortic	I:C0003504
enhancement	I:C0003504
,	O
LV	O
enlargement	I:C0149721
and	O
increased	O
TD	O
.	O

Unsuspected	O
LV	O
systolic	I:C1277187
dysfunction	I:C1277187
can	O
be	O
recognized	O
on	O
a	O
CT	B:C1641850
pulmonary	I:C1641850
angiography	I:C1641850
by	O
identification	O
of	O
decreased	O
aortic	I:C0003504
enhancement	I:C0003504
,	O
LV	O
enlargement	I:C0149721
and	O
increased	O
TD	O
.	O

Unsuspected	O
LV	O
systolic	I:C1277187
dysfunction	I:C1277187
can	O
be	O
recognized	O
on	O
a	O
CT	O
pulmonary	I:C1641850
angiography	I:C1641850
by	O
identification	O
of	O
decreased	B:C0003504
aortic	I:C0003504
enhancement	I:C0003504
,	O
LV	O
enlargement	I:C0149721
and	O
increased	O
TD	O
.	O

Unsuspected	O
LV	O
systolic	I:C1277187
dysfunction	I:C1277187
can	O
be	O
recognized	O
on	O
a	O
CT	O
pulmonary	I:C1641850
angiography	I:C1641850
by	O
identification	O
of	O
decreased	O
aortic	I:C0003504
enhancement	I:C0003504
,	O
LV	B:C0149721
enlargement	I:C0149721
and	O
increased	O
TD	O
.	O

This	O
has	O
important	O
diagnostic	O
implications	O
for	O
the	O
patient	O
presenting	O
with	O
shortness	B:C0013404
of	I:C0013404
breath	I:C0013404
,	O
chest	O
pain	I:C0008031
,	O
or	O
dyspnea	O
.	O

This	O
has	O
important	O
diagnostic	O
implications	O
for	O
the	O
patient	O
presenting	O
with	O
shortness	O
of	I:C0013404
breath	I:C0013404
,	O
chest	B:C0008031
pain	I:C0008031
,	O
or	O
dyspnea	O
.	O

This	O
has	O
important	O
diagnostic	O
implications	O
for	O
the	O
patient	O
presenting	O
with	O
shortness	O
of	I:C0013404
breath	I:C0013404
,	O
chest	O
pain	I:C0008031
,	O
or	O
dyspnea	B:C0013404
.	O

